97 related articles for article (PubMed ID: 1799355)
21. Premenstrual syndrome: a double-blind controlled trial of progesterone and placebo.
Sampson GA
Br J Psychiatry; 1979 Sep; 135():209-15. PubMed ID: 385093
[TBL] [Abstract][Full Text] [Related]
22. Efficacy of intermittent, luteal phase sertraline treatment of premenstrual dysphoric disorder.
Halbreich U; Bergeron R; Yonkers KA; Freeman E; Stout AL; Cohen L
Obstet Gynecol; 2002 Dec; 100(6):1219-29. PubMed ID: 12468166
[TBL] [Abstract][Full Text] [Related]
23. The treatment of premenstrual symptoms with mefenamic acid.
Wood C; Jakubowicz D
Br J Obstet Gynaecol; 1980 Jul; 87(7):627-30. PubMed ID: 7000168
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of a unique oral contraceptive in the treatment of premenstrual dysphoric disorder.
Freeman EW; Kroll R; Rapkin A; Pearlstein T; Brown C; Parsey K; Zhang P; Patel H; Foegh M;
J Womens Health Gend Based Med; 2001; 10(6):561-9. PubMed ID: 11559453
[TBL] [Abstract][Full Text] [Related]
25. Randomized controlled trial of the management of premenstrual syndrome and premenstrual mastalgia using luteal phase-only danazol.
O'Brien PM; Abukhalil IE
Am J Obstet Gynecol; 1999 Jan; 180(1 Pt 1):18-23. PubMed ID: 9914571
[TBL] [Abstract][Full Text] [Related]
26. Drug therapy for the premenstrual syndrome.
Shangold MM
J Reprod Med; 1983 Aug; 28(8):525-6. PubMed ID: 6355467
[TBL] [Abstract][Full Text] [Related]
27. Premenstrual syndrome in Cape Town. Part II. A double-blind placebo-controlled study of the efficacy of mefenamic acid.
Gunston KD
S Afr Med J; 1986 Aug; 70(3):159-60. PubMed ID: 3526590
[TBL] [Abstract][Full Text] [Related]
28. Premenstrual and menstrual symptom clusters and response to calcium treatment.
Alvir JM; Thys-Jacobs S
Psychopharmacol Bull; 1991; 27(2):145-8. PubMed ID: 1924661
[TBL] [Abstract][Full Text] [Related]
29. Variable dosing of sertraline for premenstrual exacerbation of depression: a pilot study.
Miller MN; Newell CL; Miller BE; Frizzell PG; Kayser RA; Ferslew KE
J Womens Health (Larchmt); 2008; 17(6):993-7. PubMed ID: 18681820
[TBL] [Abstract][Full Text] [Related]
30. A synergistic effect of a daily supplement for 1 month of 200 mg magnesium plus 50 mg vitamin B6 for the relief of anxiety-related premenstrual symptoms: a randomized, double-blind, crossover study.
De Souza MC; Walker AF; Robinson PA; Bolland K
J Womens Health Gend Based Med; 2000 Mar; 9(2):131-9. PubMed ID: 10746516
[TBL] [Abstract][Full Text] [Related]
31. Double-blind randomized crossover trial of luteal phase estrogens (Premarin) in the premenstrual syndrome (PMS).
Dhar V; Murphy BE
Psychoneuroendocrinology; 1990; 15(5-6):489-93. PubMed ID: 1966304
[TBL] [Abstract][Full Text] [Related]
32. Efficacy of depot leuprolide in premenstrual syndrome: effect of symptom severity and type in a controlled trial.
Brown CS; Ling FW; Andersen RN; Farmer RG; Arheart KL
Obstet Gynecol; 1994 Nov; 84(5):779-86. PubMed ID: 7936512
[TBL] [Abstract][Full Text] [Related]
33. Hormone profile in premenstrual tension: effects of bromocriptine and diuretics.
Andersch B; Abrahamsson L; Wendestam C; Ohman R; Hahn L
Clin Endocrinol (Oxf); 1979 Dec; 11(6):657-64. PubMed ID: 575318
[TBL] [Abstract][Full Text] [Related]
34. Persistence of premenstrual syndrome during low-dose administration of the progesterone antagonist RU 486.
Chan AF; Mortola JF; Wood SH; Yen SS
Obstet Gynecol; 1994 Dec; 84(6):1001-5. PubMed ID: 7970453
[TBL] [Abstract][Full Text] [Related]
35. Luteal-phase estradiol relates to symptom severity in patients with premenstrual syndrome.
Seippel L; Bäckström T
J Clin Endocrinol Metab; 1998 Jun; 83(6):1988-92. PubMed ID: 9626129
[TBL] [Abstract][Full Text] [Related]
36. Allopregnanolone decrease with symptom improvement during placebo and gonadotropin-releasing hormone agonist treatment in women with severe premenstrual syndrome.
Nyberg S; Bäckström T; Zingmark E; Purdy RH; Poromaa IS
Gynecol Endocrinol; 2007 May; 23(5):257-66. PubMed ID: 17558683
[TBL] [Abstract][Full Text] [Related]
37. Clomipramine administered during the luteal phase reduces the symptoms of premenstrual syndrome: a placebo-controlled trial.
Sundblad C; Hedberg MA; Eriksson E
Neuropsychopharmacology; 1993 Sep; 9(2):133-45. PubMed ID: 8216696
[TBL] [Abstract][Full Text] [Related]
38. A placebo-controlled study of the effects of L-tryptophan in patients with premenstrual dysphoria.
Steinberg S; Annable L; Young SN; Liyanage N
Adv Exp Med Biol; 1999; 467():85-8. PubMed ID: 10721042
[TBL] [Abstract][Full Text] [Related]
39. Bromocriptine (Bromergon, Lek) in the management of premenstrual syndrome.
Meden-Vrtovec H; Vujić D
Clin Exp Obstet Gynecol; 1992; 19(4):242-8. PubMed ID: 1294345
[TBL] [Abstract][Full Text] [Related]
40. Lack of effect of spironolactone on hair shaft diameter in hirsute females.
McLellan AR; Rentoul J; MacKie R; McInnes GT
Postgrad Med J; 1989 Jul; 65(765):459-62. PubMed ID: 2690044
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
